The expression of PBX3 was higher in IDH wildtype glioma patients than Isocitrate Dehydrogenase (IDH) mutant (Fig 2E and 2F), and the prognosis of IDH wildtype is worse than IDH mutant type. This evidence concerns the gene PBX3 and central nervous system cancer.